Maybe another aspect that will help progress is the new faces that hopefully are presenting. Our new director who appealed to have been a fairly senior player at Janssens preciously. In the past the original directors of pyc or Nick Woolfe seemed to be always presenting. It appealed they may have got a bit of a reputation as not being successful, at least according to bioexec. Maybe if an ex executive from Janssens is now presenting with the enthusiasm it appears then some might think "hang on a minute there might actually be something here, lets take a look"
Maybe another aspect that will help progress is the new faces...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.025(1.95%) |
Mkt cap ! $731.9M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.29 | $1.26 | $4.614M | 3.648M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19982 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.27 | 15462 | 4 |
View Market Depth
| Last trade - 13.30pm 26/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |